CeMines(TM) Creates 'BioSystems Division'
New operating unit, which will offer products and services to the research and drug discovery markets, continues CeMines' aggressive expansion
05-Aug-2004 -
Evergreen. CeMines(TM) Inc., a privately
held company founded in 2000 that employs genomics and proteomics information
as building blocks for the development of early-stage diagnostics of diseases
and therapeutics targeted for gene regulation, today announced that the
company has created a new ...
catalysts
clinical trials
diagnostics
+6